Planning Capital Management Corp Bio N Tech Se Transaction History
Planning Capital Management Corp
- $151 Billion
- Q3 2024
A detailed history of Planning Capital Management Corp transactions in Bio N Tech Se stock. As of the latest transaction made, Planning Capital Management Corp holds 451 shares of BNTX stock, worth $51,472. This represents 0.04% of its overall portfolio holdings.
Number of Shares
451
Previous 1
45000.0%
Holding current value
$51,472
Previous $81,000
66030.86%
% of portfolio
0.04%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding BNTX
# of Institutions
357Shares Held
38.3MCall Options Held
2.45MPut Options Held
2.29M-
Baillie Gifford & CO8.31MShares$948 Million0.75% of portfolio
-
Primecap Management CO Pasadena, CA4.52MShares$515 Million0.4% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M4.36MShares$498 Million2.05% of portfolio
-
Black Rock Inc. New York, NY1.9MShares$216 Million0.0% of portfolio
-
Temasek Holdings (Private) LTD Singapore, U01.81MShares$206 Million0.88% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $27.7B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...